Skip to main content
Premium Trial:

Request an Annual Quote

Loic Maurel, Cristopher McReynolds, Patrick Lynn, Gene Cartwright

Loic Maurel will begin serving as chief operating officer of ExonHit Therapeutics as of July 1. The company said that he will be appointed CEO at the next meeting of the French firm’s supervisory board.
Maurel previously served as president and CEO of Debiovision, a Canadian pharmaceutical development company. Before that, he was vice president of marketing and specialty business for Novartis Canada.
Maurel received his MD from the University of Bordeaux in France.

Cristopher McReynolds was recently named president and chief executive officer of Satoris. He replaced Patrick Lynn, who was named executive chairman. McReynolds previously was vice president of business development in the Molecular Diagnostics unit of Affymetrix.

Gene Cartwright, formerly president of GE Healthcare’s molecular diagnostics business, has been named CEO of Omnyx, a newly formed joint venture between GE Healthcare and the University of Pittsburgh Medical Center. The new JV will develop and sell advanced digital imaging systems for pathologists.
Cartwright joined GE Healthcare in late 2005 from Abbott Laboratories, where he served as vice-president of strategic programs for its molecular diagnostics business.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.